COLL vs GL
Collegium Pharmaceutical Inc (COLL) versus Globe Life Inc (GL) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Globe Life Inc (GL) is a insurance - life company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
GL does not have a complete income-statement cache yet.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. GL currently screens at market cap $10.26B and trailing P/E 10.1.
Not investment advice. Open the COLL and GL stock pages for the full models.
Not investment advice.